简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-11-07 17:53 Arima Genomics Completes Early Access Program and Launches the Arima-HiC Platform
2018-11-06 18:34 Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers
2018-11-06 17:26 OptraSCAN® Unveils High-Speed, High-Throughput, High-Capacity and High-Content “Multi-Modality Digital Slide Scanner”
2018-11-06 17:20 AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector
2018-11-06 10:00 Aurigene to Present Multiple Programs at the SITC 2018 in Washington D.C. and EORTC-NCI-AACR 2018 in Dublin
2018-11-06 09:53 Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
2018-11-05 18:00 U.S. Businessman Issues Global, Multimillion Dollar (USD) Challenge for Innovative Alzheimer’s Solutions
2018-11-05 16:28 View Announces $1.1 Billion Investment from the SoftBank Vision Fund to Meet Accelerating Demand
2018-11-02 18:03 PotNetwork Holdings, Inc. Prepares to List on Canadian Securities Exchange (“CSE”)
2018-11-02 13:34 Inflection Biosciences Announces Research Collaboration with MD Anderson
2018-11-02 11:29 Takeda Reports Second Quarter FY2018 Results
2018-11-01 14:03 Galderma, Nestlé Skin Health’s Medical Solutions Business, Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
2018-10-31 16:47 PotNetwork Holdings, Inc. Announces Diamond CBD to Pursue FDA Product Registrations
2018-10-31 13:46 NEC and Transgene Announce a Collaboration in the Field of Individualized Cancer Immunotherapy, Leveraging NEC's AI and Transgene’s myvac™ Platform
2018-10-31 10:26 Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA®▼ (D/C/F/TAF) in Treatment-Naïve Adults with HIV-1
2018-10-31 10:13 Nordson EFD Introduces Dial-A-Dose and Posi-Dose Animal Health Dosing Syringes
2018-10-30 17:46 Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer
2018-10-30 14:32 Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc
2018-10-29 19:28 Takeda to Highlight Data in Hodgkin Lymphoma During the 11th International Symposium on Hodgkin Lymphoma
2018-10-29 19:26 SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease

Business Wire Weibo

Press Releases

Latest Releases